Tag Archives: CD2

Medical Mondays @ TheHempClub.co.uk

What is the cannabinoid receptor-2 (CB2). Similar to CB1, CB2 is a G protein receptor that serves as a target for endocannabinoids and phytocannabinoids. These CB2 receptors are primarily immunomodulatory and anti-inflammatory. They are expressed on the cell membranes of B cells, T cells and macrophages. When signaled, CB2 receptors are generally inhibitory to immune cell activation. Expression of CB2

Read more

How the International Cannabis and Cannabinoid Institute started: THE ICCI

SOURCE:  THE ICCI With specific reference to Parkinson’s Disease (please read to the end of this blog for the link to the full Review). About: An undeniable global interest in the study of cannabis treatments inspired the creation of the International Cannabis and Cannabinoid Institute (ICCI), the first Center of Excellence in this field located in the heart of Europe

Read more

DEA Green Lights Epidiolex as First Cannabis Derived Pharmaceutical

SOURCE: https://www.newcannabisventures.com/dea-green-lights-epidiolex-as-first-cannabis- September 27, 2018 at 9:22 am Breaking News by Alan Brochstein, CFA The DEA has given Epidiolex, the CBD-based pharmaceutical derived from cannabis that was approved by the FDA for the treatment of rare forms of epilepsy in June, Schedule V status according to the Office of the Federal Register. The developer of the pharmaceutical, GW Pharma (NASDAQ:

Read more

Detailed analysis of selected pathological conditions and effects of cannabis and its derivatives with weaker clinical evidence and a strong theoretical basis favoring effectiveness. With reference to Parkinson’s disease.

A short quote from the .pdf (a link to the detailed analysis is at the end of this post). ” Parkinson’s disease This disease, whose symptoms especially include a decrease in the number of dopaminergic neurons in the basal ganglia (“BG”), is, due to its high prevalence (especially among older patients) and simultaneous existence of endocannabinoid receptors in the BG

Read more
« Older Entries